Physician profile
Bryan G Jefferies
NPI 1720160922
$4,754.94
in general payments reported to CMS, 2019-2025
23 companies · $1,173 in 2025
The $1,173 reported for 2025 was more than what 81% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $792 · 2020: $307 · 2021: $355 · 2022: $255 · 2023: $1,032 · 2024: $841 · 2025: $1,173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,046.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,045.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $607.40 | 2023-2025 | Istent Trabecular Micro-Bypass System Model Is3, Idosetr |
| Aerie Pharmaceuticals, INC. | $592.89 | 2019-2021 | |
| Alcon Vision LLC | $328.49 | 2020-2025 | Tryptyr, Rocklatan, Rhopressa |
| Sight Sciences, INC. | $301.13 | 2023-2024 | Omni Surgical System, Tearcare System |
| Genentech USA, INC. | $280.18 | 2022-2025 | Susvimo |
| Biotissue Holdings INC. | $255.73 | 2023 | |
| Mallinckrodt Hospital Products INC. | $251.77 | 2023-2024 | Acthar |
| Bausch & Lomb Americas INC. | $234.23 | 2023-2025 | Miebo, Vyzulta |
| Regeneron Healthcare Solutions, INC. | $231.37 | 2020-2021 | |
| Amgen INC. | $214.04 | 2024-2025 | Tepezza |
| New World Medical,INC. | $209.87 | 2025 | Clearpath, Kahook Dual Blade, Ahmed Glaucoma Valve |
| Omeros Corporation | $150.18 | 2019-2020 | |
| Alimera Sciences, INC. | $127.49 | 2019 | |
| Shire North American Group INC | $125.00 | 2019 | |
| Oyster Point Pharma, INC. | $125.00 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $123.33 | 2025 | Tecnis Iol |
| Apellis Pharmaceuticals, INC. | $119.02 | 2023 | Syfovre |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $112.45 | 2019 | |
| Abbvie INC. | $111.24 | 2024 | |
| Astellas Pharma US INC | $104.63 | 2024 | Izervay |
| Rxsight INC | $65.38 | 2023 | Rxsight Contact Lens, Rxsight Light Adjustable Lens (Rxlal), Rxsight Injector Cartridge |
| Rayner Intraocular Lenses Limited | $49.72 | 2023 | Rayone Spheric, Rayone Aspheric, Rayone Emv |
| Carl Zeiss Meditec Ag | $34.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Jefferies listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.